Phosplatin Therapeutics Inc., a clinical stage pharmaceutical company focused on oncology therapeutics, today announced an in-person poster presentation will be given at the American Academy of...

Quell Therapeutics Ltd ("Quell"), a world leader in the development of engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, today announced...

IntegriChain, delivering pharma's only comprehensive data, consulting, and business process platform for market access, today announced that Gross-to-Net (GTN) and Life Sciences accounting expert...

Chemomab Therapeutics Ltd. (Nasdaq: CMMB), (Chemomab), a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for fibrotic and inflammatory...

The 2022 Mobile World Congress (MWC) which attracted more than 2000 companies' participation was successfully held in Barcelona from February 28th to March 3rd. As the world's top mobile congress,...

Dover (NYSE: DOV) announced that its President and Chief Executive Officer, Richard J. Tobin, will present at two industry conferences this month: The J.P. Morgan Industrials Conference on...

Discovery (Nasdaq: DISCA, DISCB, DISCK) today announced that Chief Financial Officer Gunnar Wiedenfels will present at Deutsche Bank's 30th Annual Media, Internet, & Telecom Conference in Palm...

Redox, the industry-leading healthcare interoperability solution, has announced its roster of presentations and interviews at this year's HIMSS in Orlando, FL. These live sessions will take place from

Navistar solidifies its commitment to a connected and data-driven future with the standardization of a factory-installed telematics device on all new builds of the complete Class 6-8 International...

The Cloud Native Computing Foundation® (CNCF®), which builds sustainable ecosystems for cloud native software, released the schedule for KubeCon + CloudNativeCon Europe 2022, happening in...

For the sixth consecutive contest, Pine River Pre-Pack earned the Best-of-Class award in the Cold Pack Cheese Food class at the 2022 World Championship Cheese Contest held in Madison, Wisconsin...

Lightwave Logic, Inc. (NASDAQ: LWLG), a technology platform company leveraging its proprietary electro-optic (EO) polymers to transmit data at higher speeds with less power, today announced that...

Secure Exchange Solutions (SES), the leading platform provider of cloud-based, secure clinical data exchange software, will highlight their innovative product suite at the HIMSS Global Health...

Caregility, an enterprise telehealth market leader dedicated to connecting care for patients and clinicians everywhere, announces a transformative new integrated clinical solution that complements...

Jolly Good Inc. (based in Chuo-ku, Tokyo, Japan; CEO: Kensuke Joji; hereafter "Jolly Good"), known for developing and providing medical VR solutions and digital therapeutics VR programs, has...

EQT Corporation (NYSE: EQT) today unveiled its plan to unleash U.S. LNG to address the energy needs of our allies and advance climate efforts by targeting the replacement of international coal....

REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following upcoming investor conferences: Barclays Global Healthcare Conference Date: Thursday, March 17, 2022 Location:...

Posters Showcase Early-Stage Clinical and Preclinical Pipeline. Focus on ATG-037, ATG-018, ATG-022, ATG-012 and ATG-008. SHANGHAI and HONG KONG, March 9, 2022 /PRNewswire/ -- Antengene Corporation...

West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will participate in the KeyBanc Capital Markets...

DOBOT, a world-leading provider of intelligent robotic solutions, is showcasing a rich collection of robots along with the unveiling of its second-generation SCARA collaborative robot, the M1 Pro,...

Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the...

Nuvalent, Inc., (Nasdaq: NUVL) a biotechnology company creating precisely targeted therapies for clinically proven kinase targets in cancer, today announced multiple preclinical data presentations...

Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company developing the next generation of therapeutics based on its proprietary self-delivering RNAi (INTASYL™)...

Gracell to present first-in-human data on GC502, an allogeneic CD19/CD7 dual-directed chimeric antigen receptor (CAR) T cell therapy PALO ALTO, Calif. and SUZHOU, China, March 8, 2022 /PRNewswire/ --

PharmAbcine Inc. (KOSDAQ: 208340ks), a clinical-stage biotech company focusing on the development of antibody therapeutics, announced today that the Company will present the updated data of...